Parse Biosciences
WA - SeattleBiotechnology
Focus: Parse Biosciences is a Seattle-based biotechnology company specializing in single-cell sequencing technologies and applications, primarily focused on oncology research and drug discovery.
Profile data last refreshed 4h ago · AI intelligence enriched 3w ago
Open Jobs
8-2 this month
Stable — net -2 jobs in 30d
1 added, 3 removed. Backfill posture.
Should You Work at Parse Biosciences?
AI assessmentBest for scientists and commercial professionals seeking early-stage biotech exposure in enabling technology with meaningful partnerships, but requires tolerance for pre-commercial uncertainty.
Why Work Here
- Positioned at the forefront of single-cell sequencing, a high-growth enabling technology with expanding applications in precision medicine and oncology drug discovery.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Parse Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.